- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 50.18M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 50.17M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 42.35M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $6.85M |
| Capex restated | Q1 2024 · Mar 31, 2023 | $7.25M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$26.87M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$18.72M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $1.55M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.55M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $422.69M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $421.9M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$183.63M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$149.62M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $323.69M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $229.36M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.42B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.3B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $16.97M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $11.86M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.41B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.31B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.56 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.58 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.56 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.58 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $16.9M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $13.65M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$27.95M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$24.64M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$26.46M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$22.03M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | −$1.21M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | −$130K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $1.78M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $1.46M |